Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
New machine learning tools enable precise cancer subtype classification
, /in AI, E-News, Oncology /by panglobalA multi-institutional team has developed a comprehensive suite of machine learning models that can accurately classify cancer samples into molecular subtypes, bridging a critical gap between genomic research discoveries and clinical implementation.
Siemens Healthineers targets expanded global healthcare access with sustainability drive
Siemens Healthineers, /in E-News, Sustainability /by panglobalHealthcare technology leader sets ambitious targets for patient reach and environmental impact while achieving workforce diversity milestone ahead of schedule.
New guidelines set framework for Alzheimer’s disease diagnosis
Alzheimer’s, guideline, /in dementia, E-News, Neurology /by panglobalThe first comprehensive US diagnostic guidelines in two decades establish standardised evaluation process across primary and specialty care settings, emphasising a patient-centred approach and integration of emerging biomarkers.
Cellular stress mechanism links microglia to Alzheimer’s disease progression
Alzheimer’s, microglia, neurodegernation, /in dementia, E-News, Neurology /by panglobalNew research from CUNY identifies how brain immune cells drive neurodegeneration through stress-induced toxic lipid production, offering potential therapeutic targets.
Embedding sustainable principles in the design of drug delivery devices
drug delivery device, /in Drug delivery, Featured Articles, Sustainability /by panglobalAlex Fong, Insights and Sustainability Lead at Owen Mumford, explores how life-cycle assessment (LCA) is transforming the design of drug delivery devices. With single-use auto-injectors generating 400g CO₂e per unit, Fong presents innovative approaches to reduce environmental impact while maintaining critical safety standards.
Hospital hand hygiene monitoring requirements could be safely reduced, study finds
hand hygiene, /in E-News, Infection Control /by panglobalNew research suggests that reducing mandatory hand hygiene observations from 200 to 50 per unit monthly would maintain data quality while freeing resources for targeted infection prevention initiatives.
SGLT2 inhibitors emerge as key players in cardiac protection research
heart attack, /in Cardiology, E-News, Research /by panglobalA European research initiative has made significant progress in identifying new treatments to protect heart muscle during acute cardiac events, with potential implications for both diabetic and non-diabetic patients.
Genetic testing transforms care pathways for children with neurodevelopmental disorders
care pathway, Genetics, neurodevelopment, Paediatrics, /in Adolescent Health, E-News, Genetics, Neurology, Paediatrics /by panglobalUCLA Health study demonstrates significant impact of genetic diagnostics on treatment decisions and specialist referrals in complex neurodevelopmental cases, pointing towards more personalised medical approaches.
Digital workplace triggers mental health crisis as ‘techno-strain’ grips modern workforce
stress, technology, workplace, /in E-News, Editors' Picks, Psychology /by panglobalNew research from the University of Nottingham demonstrates significant psychological and physiological impacts of digital technology intensity in modern workplaces, with implications for occupational health.
electronRx launches smartphone-based lung monitoring through digital biomarkers
biomarker, chronic respiratory diseases, /in Product News, Pulmonology /by panglobalMedical technology company electronRx has developed a smartphone-based system for monitoring lung function in patients with chronic respiratory diseases (CRDs). The purpleDx app, which will launch at CES 2025 in Las Vegas, transforms mobile phones into diagnostic tools by capturing and analysing digital biomarkers through the device’s camera.